...
search icon
kg-img

KING PHARMACEUTICALS INC, Common Stock

KG

NAQ

$25.36

-$1.34

(-5.02%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$255.25M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
639
Volume info-icon
This is the total number of shares traded during the most recent trading day.
22.46K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11 L
$42.8 H
$25.36

About KING PHARMACEUTICALS INC, Common Stock

Kestrel Group Ltd engages in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers. The company is based in Hamilton, Bermuda. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameKGSectorS&P500
1-Week Return-1.25%1.81%0.78%
1-Month Return5.67%3.75%2.88%
3-Month Return49.18%-4.88%9.45%
6-Month Return-6.76%-2.96%-0.12%
1-Year Return-37.23%-6.25%11.31%
3-Year Return-49.08%12.43%61.11%
5-Year Return-4.66%39.86%96.65%
10-Year Return-91.33%83.56%189.61%

Financials

Dec '07Dec '08Dec '09Dec '23Dec '245YR TREND
Total Revenue2.14B1.57B1.78B1.33M5.25M[{"date":"2007-12-31","value":100,"profit":true},{"date":"2008-12-31","value":73.24,"profit":true},{"date":"2009-12-31","value":83.14,"profit":true},{"date":"2023-12-31","value":0.06,"profit":true},{"date":"2024-12-31","value":0.25,"profit":true}]
Cost of Revenue462.33M385.94M580.83M3.53M3.40M[{"date":"2007-12-31","value":79.6,"profit":true},{"date":"2008-12-31","value":66.45,"profit":true},{"date":"2009-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.61,"profit":true},{"date":"2024-12-31","value":0.59,"profit":true}]
Gross Profit1.67B1.18B1.20B(2.20M)1.85M[{"date":"2007-12-31","value":100,"profit":true},{"date":"2008-12-31","value":70.41,"profit":true},{"date":"2009-12-31","value":71.4,"profit":true},{"date":"2023-12-31","value":-0.13,"profit":false},{"date":"2024-12-31","value":0.11,"profit":true}]
Gross Margin78.36%75.34%67.31%(165.05%)35.20%[{"date":"2007-12-31","value":100,"profit":true},{"date":"2008-12-31","value":96.14,"profit":true},{"date":"2009-12-31","value":85.89,"profit":true},{"date":"2023-12-31","value":-210.62,"profit":false},{"date":"2024-12-31","value":44.92,"profit":true}]
Operating Expenses---2.25M1.71M[{"date":"2007-12-31","value":"-","profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":75.83,"profit":true}]
Operating Income667.43M435.37M341.66M(4.45M)141.76K[{"date":"2007-12-31","value":100,"profit":true},{"date":"2008-12-31","value":65.23,"profit":true},{"date":"2009-12-31","value":51.19,"profit":true},{"date":"2023-12-31","value":-0.67,"profit":false},{"date":"2024-12-31","value":0.02,"profit":true}]
Total Non-Operating Income/Expense---459.61K425.10K[{"date":"2007-12-31","value":"-","profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.49,"profit":true}]
Pre-Tax Income250.82M-150.59M(4.22M)354.31K[{"date":"2007-12-31","value":100,"profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":60.04,"profit":true},{"date":"2023-12-31","value":-1.68,"profit":false},{"date":"2024-12-31","value":0.14,"profit":true}]
Income Taxes67.60M131.36M58.64M-30.04K[{"date":"2007-12-31","value":51.46,"profit":true},{"date":"2008-12-31","value":100,"profit":true},{"date":"2009-12-31","value":44.64,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":0.02,"profit":true}]
Income After Taxes----324.27K[{"date":"2007-12-31","value":"-","profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations---(4.22M)324.27K[{"date":"2007-12-31","value":"-","profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-1299.96,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2007-12-31","value":"-","profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income182.98M-91.95M(4.22M)324.27K[{"date":"2007-12-31","value":100,"profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":50.25,"profit":true},{"date":"2023-12-31","value":-2.3,"profit":false},{"date":"2024-12-31","value":0.18,"profit":true}]
EPS (Diluted)-----[{"date":"2007-12-31","value":"-","profit":true},{"date":"2008-12-31","value":"-","profit":true},{"date":"2009-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KG
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KG
Debt Ratio Lower is generally better. Negative is bad. 0.24
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.76

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KG
Trailing PE 845.33
Forward PE NM
P/S (TTM) 48.02
P/B 66.47
Price/FCF 2
EV/R 47.25
EV/Ebitda 1749.58

FAQs

What is KING PHARMACEUTICALS INC share price today?

KING PHARMACEUTICALS INC (KG) share price today is $25.36

Can Indians buy KING PHARMACEUTICALS INC shares?

Yes, Indians can buy shares of KING PHARMACEUTICALS INC (KG) on Vested. To buy KING PHARMACEUTICALS INC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of KING PHARMACEUTICALS INC be purchased?

Yes, you can purchase fractional shares of KING PHARMACEUTICALS INC (KG) via the Vested app. You can start investing in KING PHARMACEUTICALS INC (KG) with a minimum investment of $1.

How to invest in KING PHARMACEUTICALS INC shares from India?

You can invest in shares of KING PHARMACEUTICALS INC (KG) via Vested in three simple steps:

  • Click on Sign Up or Invest in KG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in KING PHARMACEUTICALS INC shares
What is KING PHARMACEUTICALS INC 52-week high and low stock price?

The 52-week high price of KING PHARMACEUTICALS INC (KG) is $42.8. The 52-week low price of KING PHARMACEUTICALS INC (KG) is $11.

What is KING PHARMACEUTICALS INC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of KING PHARMACEUTICALS INC (KG) is 639

What is KING PHARMACEUTICALS INC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of KING PHARMACEUTICALS INC (KG) is 66.47

What is the Market Cap of KING PHARMACEUTICALS INC?

The market capitalization of KING PHARMACEUTICALS INC (KG) is $255.25M

What is KING PHARMACEUTICALS INC’s stock symbol?

The stock symbol (or ticker) of KING PHARMACEUTICALS INC is KG

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top